Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masamichi Kimura"'
Autor:
Hiroyuki Gatanaga, Tsunamasa Watanabe, Masayuki Kurosaki, Masamichi Kimura, Jun Imamura, Ichiro Ieiri, Kiminori Kimura, Junko Tanuma, Mikio Yanase, Tomoyuki Endo, Hiroshi Yotsuyanagi
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Objective Patients with haemophilia and HIV who acquire hepatitis C virus (HCV) after receiving contaminated blood products can experience accelerated progression of liver fibrosis and a poor prognosis, making liver disease a prominent cause of morta
Externí odkaz:
https://doaj.org/article/1600739dd4794fb68b8346d1ff583f63
Autor:
Masamichi Kimura, Koji Nishikawa, Yosuke Osawa, Jun Imamura, Kenzaburo Yamaji, Kenichi Harada, Hiroshi Yatsuhashi, Kazumoto Murata, Kouichi Miura, Atsushi Tanaka, Tatsuya Kanto, Michinori Kohara, Terumi Kamisawa, Kiminori Kimura
Publikováno v:
Hepatology Communications, Vol 6, Iss 10, Pp 2732-2747 (2022)
Abstract Chronic cholestatic liver diseases are characterized by injury of the bile ducts and hepatocytes caused by accumulated bile acids (BAs) and inflammation. Wnt/β‐catenin signaling is implicated in organ fibrosis; however, its role in choles
Externí odkaz:
https://doaj.org/article/d5276f048b864db68f6d4c442a93004d
Autor:
Eiichi Ogawa, Atsushi Tanaka, Kenichi Harada, Hiroshi Yatsuhashi, Kazumoto Murata, Masamichi Kimura, Jun Imamura, Masanao Saio, Yoshihiro Ikura, Kouichi Miura, Ichiro Ieiri, Kiminori Kimura
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Objective This study aimed to evaluate the safety and tolerability of OP-724, a CREB-binding protein/β-catenin inhibitor, in patients with advanced primary biliary cholangitis (PBC).Design An open-label, non-randomised, phase 1 trial was conducted a
Externí odkaz:
https://doaj.org/article/cabfe85f53b94df4a8a96a71c3bfa66f
Autor:
Satoshi Yamada, Takuya Yoshino, Minoru Matsuura, Masamichi Kimura, Yorimitsu Koshikawa, Naoki Minami, Takahiko Toyonaga, Yusuke Honzawa, Hiroshi Nakase
Publikováno v:
Intestinal Research, Vol 13, Iss 3, Pp 250-258 (2015)
Background/AimsThe long-term clinical outcomes of patients with bio-naive ulcerative colitis (UC) who maintain remission with thiopurine are unclear. The aim of this study was to assess the long-term efficacy and safety of maintenance treatment with
Externí odkaz:
https://doaj.org/article/06131b10447443ad9c848f58a1cdd462
Autor:
Takuya Yoshino, Minoru Matsuura, Naoki Minami, Satoshi Yamada, Yusuke Honzawa, Masamichi Kimura, Yorimitsu Koshikawa, Ali Madian, Takahiko Toyonaga, Hiroshi Nakase
Publikováno v:
Intestinal Research, Vol 13, Iss 3, Pp 266-273 (2015)
Background/AimsEarly use of biologics in patients with Crohn's disease (CD) improves quality of life. However, the effects of the early use of immunomodulators on long-term outcomes remain unclear. This study aimed to evaluate the effects of immunomo
Externí odkaz:
https://doaj.org/article/048f5f37ee504b74b366c78b3a546139
Autor:
Masamichi Kimura, Yoshihisa Tsuji, Masako Iwai, Masahiro Inagaki, Ali Madian, Takuya Yoshino, Minoru Matsuura, Hiroshi Nakase
Publikováno v:
Intestinal Research, Vol 13, Iss 2, Pp 166-169 (2015)
Behçet's disease (BD) is a systemic vasculitis, while myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic disorders characterized by ineffective hematopoiesis. Some studies suggest a relationship between MDS and BD, especia
Externí odkaz:
https://doaj.org/article/c2b12fd9f67e4bed812999d44e47b73f